← All trials
NCT04681417
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 20, 2021
- Primary completion
- Jan 20, 2035
- Completion date
- Jan 20, 2036
- First posted
- Dec 23, 2020
- Last posted
- Dec 23, 2020
- Enrollment
- 225
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Curie InstituteLead sponsor
- Adolphe Rothschild Ophtalmologic FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.